Vertex Pharmaceuticals 통합
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionFirst Quadrant L P/ca
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
First Quadrant L P/ca closes position in VRTX / Vertex Pharmaceuticals Incorporated

On April 21, 2022 - First Quadrant L P/ca filed a 13F-HR form disclosing ownership of 0 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $0 USD as of March 31, 2022. The entity filed a previous 13F-HR on January 27, 2022 disclosing 7,024 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2022-04-21 2022-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 0 -7,024 -100.00 0 -100.00
2022-01-27 2021-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,024 0 0.00 1,542 21.04 0.1659
2021-10-26 2021-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,024 2,400 51.90 1,274 36.70 0.1487
2021-07-23 2021-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 4,624 -3,671 -44.26 932 -47.73 0.1070
2021-04-27 2021-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 8,295 -5,274 -38.87 1,783 -44.40 0.1896
2021-01-27 2020-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 13,569 -1,465 -9.74 3,207 -21.61 0.3201
2020-10-28 2020-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 15,034 -2,003 -11.76 4,091 -17.29 0.5224
2020-07-28 2020-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 17,037 -5,952 -25.89 4,946 -9.58 0.6635
2020-05-05 2020-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 22,989 11,368 97.82 5,470 115.02 0.7961
2020-01-28 2019-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 11,621 -6,198 -34.78 2,544 -15.73 0.2129
2019-10-25 2019-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 17,819 -845 -4.53 3,019 -11.80 0.2842
2019-07-24 2019-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 18,664 12,360 196.07 3,423 195.09 0.2378
2019-04-24 2019-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 6,304 -878 -12.23 1,160 -2.52 0.0889
2019-01-24 2018-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 7,182 -127,235 -94.66 1,190 -95.41 0.0958
2018-10-23 2018-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 134,417 -58,510 -30.33 25,908 -20.99 0.5761
2018-07-27 2018-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 192,927 1,298 0.68 32,790 4.99 0.6144
2018-04-20 2018-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 191,629 55,646 40.92 31,232 53.26 0.5971
2018-01-23 2017-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 135,983 6,168 4.75 20,378 3.25 0.3825
2017-10-25 2017-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 129,815 127,856 6,526.60 19,737 7,732.14 0.3820
2017-07-19 2017-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 1,959 1,459 291.80 252 358.18 0.0050
2017-04-25 2017-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 500 0 0.00 55 48.65 0.0011
2017-01-26 2016-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 500 0 0.00 37 -15.91 0.0008
2016-10-19 2016-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 500 0 0.00 44 2.33 0.0009
2016-07-19 2016-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 500 0 0.00 43 7.50 0.0009
2016-04-20 2016-03-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 500 500 0.00 40 0.0009
2016-01-26 2015-12-31 13F VERTEX PHARMACEUTICALS COMMON 92532F100 0 -400 -100.00 0 -100.00
2015-10-28 2015-09-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 400 200 100.00 42 68.00 0.0009
2015-07-08 2015-06-30 13F VERTEX PHARMACEUTICALS COMMON 92532F100 200 200 25 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.